3.15
price down icon1.25%   -0.04
after-market Handel nachbörslich: 3.16 0.01 +0.32%
loading

Atea Pharmaceuticals Inc Aktie (AVIR) Neueste Nachrichten

pulisher
Dec 10, 2025

We're Keeping An Eye On Atea Pharmaceuticals' (NASDAQ:AVIR) Cash Burn Rate - Yahoo Finance

Dec 10, 2025
pulisher
Dec 04, 2025

How Atea Pharmaceuticals Inc. stock trades during market volatilityTrade Risk Assessment & Community Verified Trade Signals - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Is Atea Pharmaceuticals Inc. stock overvalued by current metricsJuly 2025 Macro Moves & Daily Growth Stock Tips - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

How Atea Pharmaceuticals Inc. stock valuations compare to rivalsTake Profit & Fast Entry High Yield Tips - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

How Atea Pharmaceuticals Inc. stock performs after earningsJuly 2025 Action & AI Enhanced Trading Signals - Newser

Dec 03, 2025
pulisher
Nov 25, 2025

ReAlta Life Sciences Appoints Dr. Howard Berman as Executive Chairman - Stock Titan

Nov 25, 2025
pulisher
Nov 23, 2025

Atea Pharmaceuticals director Franklin Berger acquires $81,498 in stock - MSN

Nov 23, 2025
pulisher
Nov 21, 2025

Will Atea Pharmaceuticals Inc. stock beat EPS estimatesTrade Risk Report & Expert Approved Momentum Trade Ideas - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Is Atea Pharmaceuticals Inc. stock reversal real or fake2025 Winners & Losers & Technical Pattern Based Buy Signals - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Atea Pharmaceuticals Inc. stock outperform growth indexesJuly 2025 Action & Momentum Based Trading Ideas - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

How strong is Atea Pharmaceuticals Inc. stock revenue growth2025 Historical Comparison & Growth Focused Investment Plans - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Atea Pharmaceuticals Inc (AVIR) Q3 2025 Earnings Call Highlights: Strategic Advances in HCV ... By GuruFocus - Investing.com Canada

Nov 19, 2025
pulisher
Nov 19, 2025

Atea Pharmaceuticals to Present at the 8th Annual Evercore Healthcare Conference - Yahoo Finance

Nov 19, 2025
pulisher
Nov 19, 2025

Is a relief rally coming for Atea Pharmaceuticals Inc. holdersProduct Launch & High Return Trade Opportunity Guides - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

How Atea Pharmaceuticals Inc. stock performs in rate cut cyclesQuarterly Earnings Summary & Reliable Intraday Trade Alerts - newser.com

Nov 18, 2025
pulisher
Nov 17, 2025

Atea Pharma (AVIR) Earnings Call Transcript - AOL.com

Nov 17, 2025
pulisher
Nov 17, 2025

William Blair Has Negative Outlook of AVIR FY2025 Earnings - Defense World

Nov 17, 2025
pulisher
Nov 16, 2025

Atea Pharmaceuticals Inc. stock trend outlook and recovery pathMarket Growth Report & Reliable Price Action Trade Plans - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Live market analysis of Atea Pharmaceuticals Inc.CEO Change & AI Enhanced Market Trend Forecasts - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Backtesting results for Atea Pharmaceuticals Inc. trading strategiesJuly 2025 Summary & Real-Time Market Sentiment Reports - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Atea Pharmaceuticals’ Earnings Call Highlights Progress and Optimism - MSN

Nov 15, 2025
pulisher
Nov 15, 2025

Key metrics from Atea Pharmaceuticals Inc.’s quarterly dataMarket Trend Report & Fast Moving Stock Trade Plans - newser.com

Nov 15, 2025
pulisher
Nov 14, 2025

What Makes HDFC Mutual fund a Strong Contender in YEAREarnings Call Summaries & Fast Growing Portfolio - earlytimes.in

Nov 14, 2025
pulisher
Nov 14, 2025

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 14, 2025
pulisher
Nov 14, 2025

Atea Pharmaceuticals, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:AVIR) 2025-11-14 - Seeking Alpha

Nov 14, 2025
pulisher
Nov 12, 2025

Atea Pharmaceuticals Advances Antiviral Programs with New Data - TipRanks

Nov 12, 2025
pulisher
Nov 12, 2025

Atea Pharmaceuticals Q3 2025 Earnings Call Transcript - MarketBeat

Nov 12, 2025
pulisher
Nov 12, 2025

Earnings call transcript: Atea Pharmaceuticals Q3 2025 sees EPS miss By Investing.com - Investing.com Nigeria

Nov 12, 2025
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Kapitalisierung:     |  Volumen (24h):